Medications

Five key things to know about data on adverse effects

The potential harms of interventions are tricky to get a handle on. Our feelings about them are, too. It wouldn't be easy – even if we didn't have to deal with people trying to beat up, or minimize, the risks of treatments. ...

Surgery

Cutting-edge kidney transplant a first: surgeons

A sister-to-sister kidney transplant in France reported Wednesday is the first to combine robotics, vaginal access and the donated organ's immediate implant after removal, according to the surgeons.

Medications

FDA launches first app to identify drug shortages

(HealthDay)—A mobile phone application (app) has been released to identify current drug shortages, resolved shortages, or discontinuations of drug products, according to a press release published by the U.S. Food and Drug ...

Health

CMS launches initiative to assist newly insured

(HealthDay)—A national initiative has been launched to help answer questions that people may have about their new health coverage and to offer health providers the tools needed to promote patient engagement, according to ...

Oncology & Cancer

Blood clue to prostate cancer recurrence

Men with blood group O are far less likely to suffer a recurrence of cancer after prostate tumour surgery than men with other blood types, researchers reported on Monday.

Medications

FDA: Zofran 32-mg dose pulled from market

(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

page 10 from 10